Immunofluorescence assay to process 240+ samples per hour.
Fast Time to Result
Reaction takes 15mins – then AFS-1000 gives result in under 10 seconds.
Test for COVID-19 infection with Sensitivity, Specificity and Limit of Detection on a par with LAMP and PCR.
We provide cutting edge point-of care diagnostic technologies.
Platforms that can run multiple immunofluorescence chromatography assays – including for active COVID-19 infection and IgG / IgM.
100% Concordance with PCR
In independent clinical trials, the AFS-1000 with the COVID-19 cassette agreed 100% with all positive clinical samples to a Ct value of 39 on PCR.
Neutralising Antibody Test
Test now available for neutralising antibodies against the viral spike protein – the antibodies elicited by current vaccines.
Scale, Speed and Support
We’ve partnered with one of the world’s largest manufacturers of high-tech diagnostic reagents and instruments to give you cost-efficient, rapid, easy-to-operate diagnostics.
How do we measure accuracy?
Most manufacturers brag about sensitivity and specificity.
But that’s not the whole picture. Those are of little use if a test only identifies people with the highest levels of virus.
Sensitivity is the ability of a test to correctly identify patients with a disease.
Specificity is the ability of a test to correctly identify patients without the disease.
Limit of Detection
How much virus needs to be in the sample for a reliably positive result.
The MFX Biotech machine reader with our exclusive COVID-19 assay has a Limit of Detection of 0.5TCID50/ml or 0.02ng/ml of n-protein. That means it can detect viral levels down to 100 copies per ml – as low as many PCR and LAMP tests. For comparison, visually-read lateral flow devices need at least 200-300x more virus present to give a positive result.
Our test exceeds the highest standard for performance characteristics set by the MHRA.
Only diagnoses active infections: no false positives due to past infections – unlike PCR and LAMP
Meet the Team
A wealth of experience in supporting the medical industry backed up with scientific and logistical expertise.
Paul has more than twenty years’ experience in various commercial roles. His background includes senior positions in Forex, marketing, aviation, and business management.
Simon has a wealth of board experience in an eclectic mix of industries from biotech to precious metals to FMCG. Simon leads the MFX client exerience team and relishes the complex challenges that COVID-19 testing presents.
Please get in touch and one of our team will be in contact. No pushy salesmen – promise – we just let the science do the talking.